Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,489,301 papers from all fields of science
Search
Sign In
Create Free Account
Recurrent Digestive System Carcinoma
Known as:
Recurrent Gastrointestinal System Cancer
, Recurrent Gastrointestinal System Carcinoma
The reemergence of carcinoma in any part of the digestive system after a period of remission.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Epithelial Cells
Epithelium
Gastrointestinal system
Malignant Epithelial Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer
Jin Sun
,
M. Qiu
,
+5 authors
Su Li
Translational cancer research
2020
Corpus ID: 214757979
Background Biomarkers in serum may have important clinical implications for personalized medicine, including therapeutic guidance…
Expand
2016
2016
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer
B. Han
,
Joo Jung
,
+12 authors
D. Zang
Cancer Chemotherapy and Pharmacology
2016
Corpus ID: 22449346
PurposesTo determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined oxaliplatin, irinotecan…
Expand
2014
2014
[Value of the palliative prognostic index, controlling nutritional status, and prognostic nutritional index for objective evaluation during transition from chemotherapy to palliative care in cases of…
T. Fukushima
,
K. Annen
,
Y. Kawamukai
,
Noritomo Onuma
,
M. Kawashima
Gan to kagaku ryoho. Cancer & chemotherapy
2014
Corpus ID: 7390348
OBJECTIVE We investigated whether objective evaluation by using the palliative prognostic index(PPI), controlling nutritional…
Expand
2014
2014
671PDOSE FINDING STUDY OF OXALIPLATIN, IRINOTECAN, AND S-1 FOR PATIENTS WITH METASTATIC OR RECURRENT GASTROINTESTINAL CANCER.
B. Han
,
H. Kim
,
+11 authors
D. Zang
Annals of oncology : official journal of the…
2014
Corpus ID: 1346686
ABSTRACT Aim: To determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined oxaliplatin…
Expand
2013
2013
Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer
M. Iwatsuki
,
K. Toyoshima
,
+9 authors
H. Baba
British Journal of Cancer
2013
Corpus ID: 575874
Background:The clinical significance of circulating tumour cell (CTC) detection in gastrointestinal (GI) cancer remains…
Expand
2010
2010
[Oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients].
T. Nishimura
,
K. Sakata
,
+6 authors
Satoyoshi Yamashita
Gan to kagaku ryoho. Cancer & chemotherapy
2010
Corpus ID: 1429370
The aim of this study was to introduce an oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer…
Expand
2004
2004
A phase I study of immunotherapy with tumor cell-dendritic cell fusion vaccine in patients with advanced or recurrent gastrointestinal cancer
K. Okinaga
,
H. Iinuma
,
T. Ogiwara
,
F. Ogawa
2004
Corpus ID: 201155750
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against…
Expand
2004
2004
A phase I study of immunotherapy with tumor cell-dendritic cell fusion vaccine in patients with advanced or recurrent gastrointestinal cancer.
K. Okinaga
,
H. Iinuma
,
T. Ogiwara
,
F. Ogawa
Journal of clinical oncology : official journal…
2004
Corpus ID: 11186721
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against…
Expand
1990
1990
[Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90…
K. Sugihara
,
C. Auther
,
+7 authors
G. Kōsaki
Gan to kagaku ryoho. Cancer & chemotherapy
1990
Corpus ID: 2091405
Early phase II study in patients with advanced and recurrent gastrointestinal cancer was conducted from August 1986 through…
Expand
Highly Cited
1985
Highly Cited
1985
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer.
H. Staab
,
F. A. Anderer
,
E. Stumpf
,
A. Hornung
,
R. Fischer
,
G. Kieninger
American journal of surgery
1985
Corpus ID: 25284954
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE